Mistakes when selecting and managing front-line leaders can quickly impede the success of your sales team. Drawing on insights from Mix Talent's I/O Psychology consultants, this white paper outlines how #lifesciences sales leaders can identify and avoid nine common pitfalls and set FLLs up for success. Read the full white paper here! #sales #mixtalent #assessments #leadership #talentacquisition
Mix Talent
Staffing and Recruiting
Columbus, Ohio 41,253 followers
Culture is built by people. And runs on talent.
About us
Mix Talent was built to support the near-term goals and long-term success of pharma, biotech, HealthTech, and gene therapy organizations. We recognize the power of your company culture, and we specialize in identifying, recruiting, assessing, selecting, and developing talent that fits and fortifies that culture. As our name demonstrates, we believe it’s essential to find that right mix of skills, experience, personality, and personal motivation to ensure long-term success. And to do that, you need to do it differently. Our unique mix of knowledge, technology, and instinct has helped clients go beyond just hiring headcount to truly creating dynamic organizations. The secret’s in the mix.
- Website
-
https://www.mix-talent.com
External link for Mix Talent
- Industry
- Staffing and Recruiting
- Company size
- 51-200 employees
- Headquarters
- Columbus, Ohio
- Type
- Partnership
- Founded
- 2018
Locations
-
Primary
1349 W Lane Ave
1010
Columbus, Ohio 43221, US
Employees at Mix Talent
Updates
-
We hope everyone has had a chance to relax and unwind this summer! ☀ While truly unplugging from work can be a challenge during vacation, it's so important for our well-being, creativity, and sustainability. Whether you're lounging on the beach, exploring a new city, or soaking in nature, what are your favorite ways to disconnect and unwind? Share your tips in the poll below! #SummerVacation #PTO #Unplugging #MixTalent
This content isn’t available here
Access this content and more in the LinkedIn app
-
This past weekend, Mix Talent was honored to participate in Pelotonia, raising money for cancer research at the Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute. A huge thank you to the Mixers who 🚴♂️ and to everyone who helped us reach our fundraising goals 💸! #onegoal #pelotonia #cancerresearch #ohiostateuniversity #fundraising The Ohio State University Drew Leininger Drew Rothschild Glenna Halligan Stephanie McGinty
-
-
-
-
-
+1
-
-
We loved hosting Chloe Bender Johnston and The Ohio State University Center for Software Innovation team for a tour of our new space as inspiration for the build out of their new Carmenton district offices! O-H!
Over the past month, we have been doing tours of awesome offices around Columbus. We're gathering inspiration for the two floors The Ohio State University Center for Software Innovation will occupy in the future Commercialization and Entrepreneurship Center in the Carmenton district. In addition to Mix Talent's new office (w/ Drew Rothschild), we've toured IBM (thanks Nancy Kramer!) and Aware (hi Jeff Schumann!). I love these tours. The designers always have such unique insights of what's worked well, what they'd change, and what behaviors differ from what they initially thought. Where else should we check out in the Columbus area for good office inspo & #vibes? ⬇ (also, go easy on me. this was my first reel 👵 ).
-
Today, Mix is 6! 🎉 Over these energetic years, we've solved challenges, created win-win relationships, cared for one another, and delivered incredible results. We could not be more grateful to our amazing team, clients, and partners for their ongoing support and dedication. Here's to celebrating our journey thus far and looking forward to many more to come. Thank you for being in the mix! 🌟🥂
-
Exceptional Commercial and HealthTech leaders are hard to find – that's where our team of #lifesciences recruiters come in. Check out our recently filled roles and reach out to discuss your next great hire: https://lnkd.in/gK6cAWh2 #mixtalent #recruiting #talentacquisition #executivesearch
-
-
Great news from Yamo Pharmaceuticals on their novel therapy targeting the core symptoms of autism! 👏 “We are excited to receive these results in the hope to offer patients and their families a treatment option that can impact the core symptoms of ASD.” — Chuck Bramlage, Yamo’s Chief Executive Officer.
Exciting news! Yamo Pharmaceuticals Announces Positive Topline Results from Phase 2 Study of L1-79 for the Treatment of the Core Symptoms of Autism https://lnkd.in/eR7qk6NJ
Yamo Pharmaceuticals Announces Positive Topline Results from Phase 2 Study of L1-79 for the Treatment of the Core Symptoms of Autism
finance.yahoo.com
-
Incredible news today 🗞️ for Vertex Pharmaceuticals and patients struggling with acute pain. “The FDA’s granting of a priority review further reinforces the high unmet need in treating acute pain, and the filing brings us one step closer to our objective of filling the gap between medicines with good tolerability but limited efficacy and opioid medicines with therapeutic efficacy but known risks, including addictive potential.” — Nia Tatsis Ph.D., Executive Vice President, Chief Regulatory and Quality Officer
We are excited to share that the FDA has accepted and granted priority review to the New Drug Application (NDA) submission for our investigational acute pain medicine. Learn more: https://lnkd.in/e82MZEJF
-
Exciting news for Ironshore! “Our team has worked tirelessly to bring Jornay PM to the ADHD community and we are excited that Collegium recognizes Jornay PM’s long-term potential and is committed to supporting its continued growth,” said Stephanie Read, Chief Executive Officer.
Collegium is excited to announce the proposed acquisition of Ironshore. We are proud to be taking this important next step for our organization as we strive to build a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Read more: https://bit.ly/46FQ2Ln
-
-
Industry insight 💡 As IPO's have slowed down in 2024, private biotech acquisitions have taken their place, a phenomenon industry watchers say is driven by the abundance of mature, but not yet public, drug startups. https://lnkd.in/etnEYd7t
Private biotech M&A surges amid difficult IPO market
biopharmadive.com